Skip to content

The Biological Basis Research of Qi-deficiency Syndrome based on ZangFu in TCM: A systematic clinical study to explore the biological basis of stable coronary heart disease with Qi-deficiency syndrome

The Biological Basis Research of Qi-deficiency Syndrome based on ZangFu in TCM: A systematic clinical study to explore the biological basis of stable coronary heart disease with Qi-deficiency syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017506
Enrollment
Unknown
Registered
2018-08-02
Start date
2018-08-06
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stable coronary heart disease

Interventions

Patients with stable coronary heart disease:none
normal control:none

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 35-75 years old, male or female; 2. TCM diagnosis of Qi-deficiency syndrome; 3. Meeting the diagnostic criteria of stable coronary artery diseases; 4. Volunteers participate with signed the Letter of Informed and Consent.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with acute myocardial infarction, unstable angina or chest pain due to other heart diseases, severe neurosis, menopause syndrome and cervical spondylosis; 2. Patients with major systemic diseases combined such as the nervous system, and immune system, or poorly controlled chronic diseases such as hypertension and diabetes; 3. Patients with severe liver and kidney function damage, with alanine aminotransferase> 3 times of the upper limit of normal, or serum creatinine> 265umol/L; 4. Those who have complicated accompanying syndromes, including excess syndromes such as phlegm, coldness, and heat toxicity, as well as patients with obvious Yin-deficiency or Yang-deficiency; 5. Patients with allergic constitution; 6. Women who are in pregnancy, lactation or menstruation; 7. Patients who participated in other drug clinical trials in the past 1 month; 8. Patients with mental disorders, neurological impediments, or failure to express themselves or communicate; 9. Alcoholics, drug abusers and addicts.

Design outcomes

Primary

MeasureTime frame
The syndrome scorings of the Qi-deficiency;

Countries

China

Contacts

Public ContactHao Xu

Xiyuan Hospital of China Academy of Chinese Medical Sciences

jiang_yuerong@163.com+86 18601081161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026